New CEU/CME Course Available: Psychiatric Medications and Long-term Outcomes for Schizophrenia

The Mad in America Continuing Education Project is pleased to announce the posting of its second on-line course. This course qualifies for 3.0 CMEs  approved by the American Academy of Family Physicians and 2.5 CEUs approved by Commonwealth Educational Seminars for psychologists, social workers, licensed marriage and family counselors, nurses and certified addiction counselors. We […]

Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients

Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Atsuko-Ikenouchi Sugita, Kiyokazu Atake, Jun Nakamura Department of Psychiatry, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 8078555, Japan Abstract Objective This study sought to examine whether switching polypharmacy therapy to monotherapy would improve the cognitive function and social function of patients with schizophrenia.

NIMH Director’s Blog: Antipsychotics: Taking the Long View

One of the first lessons I received as a psychiatrist-in-training 35 years ago was the value of antipsychotic medications. These medicines have been available for the treatment of psychosis for over half a century, beginning with the prototype first generation drug chlorpromazine (Thorazine) and now extending to some 20 different compounds, including several second-generation medications, […]

All Sorts of Realities

In previous posts in this series, I noted that the standard treatment of conditions labeled as schizophrenia (and related disorders) is to start neuroleptics early and to continue them indefinitely. This is based on the belief that untreated psychosis is bad for the brain and that relapse is much higher when the drugs are stopped […]

“Recovery” Is Not Just a Fad

I want to talk briefly about “recovery.” Many clinicians and program directors were trained, as I was, to think that regaining marginal improvement or downward course were the only two options open for persons with repeated episodes of serious and persistent psychiatric problems, such as the group of schizophrenias, major depressions, or bipolar disorders. However, […]